The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Pathogen resistance 6
Rituximab Peripheral swelling 6
RITUXIMAB Prescribed underdose 6
rituximab Protein total decreased 6
RITUXIMAB Rash maculo-papular 6
rituximab Skin reaction 6
Rituximab Skin ulcer 6
Rituximab Small intestinal resection 6
Rituximab Spinal compression fracture 6
Rituximab Transient ischaemic attack 6
RITUXIMAB Vaccine virus shedding 6
RITUXIMAB Venoocclusive liver disease 6
rituximab Vitamin B12 increased 6
RITUXIMAB White matter lesion 6
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Fatigue 6
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Febrile neutropenia 6
RITUXIMAB Abdominal abscess 5
Rituximab Adverse drug reaction 5
RITUXIMAB Arrhythmia 5
RITUXIMAB Atypical pneumonia 5

Total Records: 1,104     Number of Pages: 56